Comprehensive Transplant Center, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
J Am Soc Nephrol. 2022 Dec;33(12):2293-2305. doi: 10.1681/ASN.2022030296. Epub 2022 Aug 31.
In single-center studies, HLA-DQ mismatches stimulate the most pathogenic donor-specific antibodies. However, because of limitations of transplant registries, this cannot be directly confirmed with registry-based analyses.
We evaluated patients in the Scientific Registry of Transplant Recipients who were relisted after renal graft failure with new, unacceptable antigens corresponding to the HLA typing of their previous donor (UA-PD) as a proxy for donor-specific antibodies. Linear regression was applied to estimate the effects of HLA mismatches on UA-PD and the effects of UA-PD on calculated panel reactive antibody (cPRA) values for 4867 kidney recipients from 2010 to 2021.
Each additional HLA-DQ mismatch increased the probability of UA-PD by 25.2% among deceased donor transplant recipients and by 28.9% among living donor transplant recipients, significantly more than all other HLA loci (<0.05). HLA-DQ UA-PD increased cPRA by 29.0% in living donor transplant recipients and by 23.5% in deceased donor transplant recipients, significantly more than all loci except for HLA-A in deceased donor transplant recipients (23.1%). African American deceased donor transplant recipients were significantly more likely than Hispanic and White recipients to develop HLA-DQ UA-PD; among living donor transplant recipients, African American or Hispanic recipients were significantly more likely to do so compared with White recipients. Models evaluating interactions between HLA-DR/DQ mismatches revealed largely independent effects of HLA-DQ mismatches on HLA-DQ UA-PD.
HLA-DQ mismatches had the strongest associations with UA-PD, an effect that was greatest in African American and Hispanic recipients. cPRA increases with HLA-DQ UA-PD were equivalent or larger than any other HLA locus. This suggests a need to consider the effects of HLA-DQ in kidney allocation.
在单中心研究中,HLA-DQ 错配会刺激最具致病性的供体特异性抗体。然而,由于移植登记处的限制,这不能通过基于登记处的分析直接确认。
我们评估了 Scientific Registry of Transplant Recipients 中因新的、不可接受的抗原而导致肾移植失败后重新配型的患者,这些抗原与他们之前供体的 HLA 分型相对应(UA-PD),作为供体特异性抗体的替代指标。线性回归用于估计 HLA 错配对 UA-PD 的影响,以及 UA-PD 对 2010 年至 2021 年间 4867 名肾移植受者计算的群体反应性抗体 (cPRA) 值的影响。
在尸肾移植受者中,每增加一个 HLA-DQ 错配,UA-PD 的可能性增加 25.2%,在活体供者移植受者中增加 28.9%,明显高于其他所有 HLA 位点(<0.05)。HLA-DQ UA-PD 使活体供者移植受者的 cPRA 增加 29.0%,使尸肾移植受者的 cPRA 增加 23.5%,明显高于除 HLA-A 以外的所有位点(23.1%)。与西班牙裔和白人受者相比,非洲裔美国尸肾移植受者发生 HLA-DQ UA-PD 的可能性明显更高;在活体供者移植受者中,与白人受者相比,非洲裔或西班牙裔受者发生 HLA-DQ UA-PD 的可能性明显更高。评估 HLA-DR/DQ 错配相互作用的模型显示,HLA-DQ 错配对 HLA-DQ UA-PD 的影响基本独立。
HLA-DQ 错配与 UA-PD 关联最强,在非裔美国人和西班牙裔受者中影响最大。UA-PD 与 cPRA 增加的相关性与任何其他 HLA 位点相同或更大。这表明在肾脏分配时需要考虑 HLA-DQ 的影响。